Delivery Order SPE2DB25D3005-SPE2DB25FQEYD
Award Date 5/7/25
Potential Completion Date 5/29/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of May 12, 2025. This non-set-aside award was issued on April 21, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, valued at $8,313.12, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, demonstrating the agency's ongoing need...
- The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is not subject to a set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $1,385.52 for 30 tablets of Orgovyx 120 mg on August 19, 2025, with completion expected by September 10, 2025. The contract, which carries no set-aside designation, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing a specialized pharmaceutical commodity within the...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of November 13, 2025. This competitive award, issued on October 22, 2025, carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.06. This firm fixed-price delivery order is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. Orgovyx is a prescription medication used...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count bottles) on April 24, 2025, with a completion date of May 15, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of advanced prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for supply of Orgovyx 120 mg tablets (30-count units) on August 13, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Orgovyx is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced...